# FMC Corp: Form 10-Q for the period ended Sep 30, 2013

- Company: [FMC Corp](/companies/fmc.md) (CIK 37785)
- Form: 10-Q
- Filed: 2013-10-29
- Accepted by EDGAR: Oct 29, 2013, 19:15 ET
- Period: 2013-09-30
- Accession: 0000037785-13-000050
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/37785/000003778513000050/fmc930201310q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/37785/000003778513000050/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-07-01 to 2013-09-30 | $957.4m | us-gaap:Revenues |
| Revenue | 9 months, 2013-01-01 to 2013-09-30 | $2.74bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2013-07-01 to 2013-09-30 | $653.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2013-01-01 to 2013-09-30 | $1.76bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2013-07-01 to 2013-09-30 | $304.4m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2013-01-01 to 2013-09-30 | $985.5m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2013-07-01 to 2013-09-30 | $124.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2013-01-01 to 2013-09-30 | $374.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-07-01 to 2013-09-30 | $118.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2013-01-01 to 2013-09-30 | $479.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2013-07-01 to 2013-09-30 | $32.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2013-01-01 to 2013-09-30 | $113.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-07-01 to 2013-09-30 | $17.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2013-01-01 to 2013-09-30 | $266.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2013-01-01 to 2013-09-30 | $1.95 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-07-01 to 2013-09-30 | $0.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2013-01-01 to 2013-09-30 | $1.96 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-07-01 to 2013-09-30 | 134,962,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2013-01-01 to 2013-09-30 | 136,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2013-01-01 to 2013-09-30 | $380.6m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months, 2013-01-01 to 2013-09-30 | $159.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2013-01-01 to 2013-09-30 | $55.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2013-01-01 to 2013-09-30 | $359.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2013-09-30 | $109.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-09-30 | $2.61bn | us-gaap:AssetsCurrent |
| Total assets | at 2013-09-30 | $4.93bn | us-gaap:Assets |
| Current liabilities | at 2013-09-30 | $2.07bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | at 2013-09-30 | $771.8m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2013-09-30 | $23.3m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2013-09-30 | $919.1m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2013-09-30 | $1.32bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2013-09-30 | 133,273,849 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 60,278 characters.

Item 2 of this report contains certain forward-looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information.

Whenever possible, we have identified these forward-looking statements by such words or phrases as “will likely result”, “is confident that”, “expects”, “should”, “could”, “may”, “will continue to”, “believes”, “anticipates”, “predicts”, “forecasts”, “estimates”, “projects”, “potential”, “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for our company based on currently available information. The forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed in, or implied by, these statements. These statements are qualified by reference to the section “Forward-Looking Statements” in Part II of our Annual Report on Form 10-K for the year ended December 31, 2012 (the “2012 10-K”) and to similar disclaimers in all other reports and forms filed with the Securities and Exchange Commission (“SEC”). We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made.

We further caution that the list of risk factors in Item 1A in Part I of the 2012 10-K may not be all-inclusive, and we specifically decline to undertake any obligation to publicly revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

### APPLICATION OF CRITICAL ACCOUNTING POLICIES

Our consolidated financial statements are prepared in conformity with U.S. generally accepted accounting principles. The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have described our accounting policies in Note 1 to our consolidated financial statements included in our 2012 10-K. We have reviewed these accounting policies, identifying those that we believe to be critical to the preparation and understanding of our consolidated financial statements. We have reviewed these critical accounting policies with the Audit Committee of our Board of Directors. Critical accounting policies are central to our presentation of results of operations and financial condition and require management to make estimates and judgments on certain matters. We base our estimates and judgments on historical experience, current conditions and other reasonable factors.

The following is a list of those accounting policies that we have deemed most critical to the presentation and understanding of our results of operations and financial condition. See the “Application of Critical Accounting Policies” section in our 2012 10-K for a detailed description of these policies and their potential effects on our results of operations and financial condition.

- Environmental obligations and related recoveries
- Impairment and valuation of long-lived assets
- Pensions and other postretirement benefits
- Income taxes

We did not adopt any changes in the current period that had a material effect on these critical accounting policies nor did we make any changes to our accounting policies that would have changed these critical accounting policies.

### RECENTLY ISSUED AND ADOPTED ACCOUNTING PRONOUNCEMENTS AND REGULATORY ITEMS

See Note 2 to our condensed consolidated financial statements included in this Form 10-Q for a discussion of recently adopted accounting guidance and other new accounting guidance.

### OVERVIEW

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in three distinct business segments: FMC Agricultural Solutions, FMC Health and Nutrition and FMC Minerals. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals – insecticides, herbicides and fungicides – with particular strength in insecticides and herbicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as pest control in non-agricultural markets. The FMC Health and Nutrition segment focuses on food ingredients that are used to enhance texture, color, structure and physical stability, pharmaceutical additives for binding, encapsulation and disintegrant applications and ultrapure biopolymers for medical devices. Our FMC Minerals segment manufactures a wide range of inorganic materials including soda ash and lithium. Soda ash is utilized in markets such as glass and detergents and lithium utilized in energy storage, specialty polymers and pharmaceutical synthesis in industrial uses.

Beginning with the third quarter 2013 our FMC Peroxygens segment has been accounted for as a discontinued operation. Prior period information has been recasted. For additional information on discontinued operations, refer to Note 10 in our notes to the condensed consolidated financial statements within this Form 10-Q.

### Third Quarter 2013 Highlights

The following are the more significant developments in our businesses during the three months ended September 30, 2013:

- Revenue of $957.4 million for the three months ended September 30, 2013 increased $135.5 million or 16 percent versus the same period last year. Revenue increases are associated with sales growth in all segments. A more detailed review of revenues by segment is discussed under the section titled "Results of Operations". On a regional basis, sales in Latin America increased by 29 percent, sales in North America were up 11 percent, sales in Asia were up six percent and sales in Europe, Middle East and Africa increased by eight percent.
- Our gross margin, excluding acquisition related charges, increased by approximately $8 million or approximately three percent to $306.5 million versus last year's third quarter driven by higher volumes and pricing primarily in our FMC Agricultural Solutions segment partially offset by unfavorable foreign currency impacts. Gross margin percent of 32 percent declined from 36 percent, primarily as a result of unfavorable geographic mix of sales in FMC Agricultural Solutions and the aforementioned unfavorable currency impacts.
- Selling, general and administrative expenses, excluding non-operating pension and postretirement charges and acquisition/divestiture related charges, increased by approximately $4 million or four percent to $114.6 million. The increase period over period is largely due to increased spending on targeted growth initiatives to meet the growth in our business. The majority of these increases were experienced in our FMC Agricultural Solutions segment.
- Research and Development expenses of $29.0 million increased $0.9 million or three percent.
- Adjusted after-tax earnings from continuing operations attributable to FMC stockholders of $110.2 million increased $3.1 million or three percent primarily due to higher operating results in FMC Agricultural Solutions, slightly offset by a higher effective tax rate. See the disclosure of our Adjusted Earnings Non-GAAP financial measurement below, under the section titled "Results of Operations".
- In July 2013, we acquired Epax Nutra Holding III AS and Epax UK Holding III AS (together, “Epax”). Epax is a global supplier of fish-based omega-3 EPA/DHA fatty acid concentrates. Epax will be integrated into our newly formed FMC Health and Nutrition segment from the acquisition date. The acquisition of Epax is an important step in fulfilling our strategic intent to broaden our product and customer base within our Health and Nutrition segment.
- In August 2013, we concluded a licensing agreement with Belchim Crop Protection for access to valifenalate, a fungicide which will be introduced into our Agricultural Solutions segment. Our rights are exclusive for use in mixtures in the Americas as well as select countries in Asia. The product is already registered and sold in certain countries in Latin America, and we plan to register in many other countries in our territory.
- In late September and early October 2013, we entered into two separate transactions that together provide our Agricultural Solutions segment with a strong foundation for developing, manufacturing and marketing biologically-based products to enhance yields and respond to evolving pest pressures and resistance. Namely, we acquired the assets of the Center for Agricultural and Environmental Biosolutions (CAEB), based in Research Triangle Park, NC, including CAEB’s robust library of microorganisms and a pipeline of biological products in various stages of development. Further, in October 2013, we entered into an exclusive collaboration with Chr. Hansen A/S, a leading global biosciences company with expertise in screening, fermentation, and scale up of microbially-based products. Together with Agricultural Solutions’

existing capabilities, we believe these transactions establish FMC as an industry leader in the growing market for biologically-based agricultural products.

### RESULTS OF OPERATIONS

### Overview

The following presents a reconciliation of our segment operating profit to the net income attributable to FMC stockholders as seen through the eyes of our management. For management purposes, we report the operating performance of each of our business segments based on earnings before interest and income taxes excluding corporate expenses, other income (expense), net and corporate special income/(charges).

*SEGMENT RESULTS RECONCILIATION*

*(in Millions)*

| 2013 Revenue | Three Months Ended September 30 | 2012 | Nine Months Ended September 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| FMC Agricultural Solutions | $530.2 | $423.6 | $1,468.0 | $1,271.4 |
| FMC Health and Nutrition | 190.4 | 173.7 | 572.2 | 512.7 |
| FMC Minerals | 237.8 | 224.6 | 706.8 | 710.3 |
| Eliminations | (1.0) | — | (2.9) | — |
| Total | $957.4 | $821.9 | $2,744.1 | $2,494.4 |
| **Income (loss) from continuing operations before income taxes** |  |  |  |  |
| FMC Agricultural Solutions | $114.2 | $100.9 | $402.2 | $343.7 |
| FMC Health and Nutrition | 41.1 | 40.3 | 129.1 | 126.0 |
| FMC Minerals | 27.7 | 34.6 | 92.1 | 127.1 |
| Eliminations | (0.1) | 0.1 | (0.3) | 0.1 |
| **Segment operating profit** | 182.9 | 175.9 | $623.1 | $596.9 |
| Corporate and other | (20.1) | (16.2) | (60.2) | (56.6) |
| Operating profit before the items listed below | 162.8 | 159.7 | 562.9 | 540.3 |
| Interest expense, net | (9.8) | (9.8) | (31.4) | (30.3) |
| Corporate special (charges) income: |  |  |  |  |
| Restructuring and other (charges) income | (32.1) | (5.5) | (47.3) | (9.1) |
| Non-operating pension and postretirement charges (1) | (5.7) | (8.1) | (30.0) | (26.3) |
| Acquisition related charges (2) | (6.7) | (0.6) | (6.7) | (7.2) |
| Provision for income taxes | (32.0) | (29.9) | (113.1) | (113.2) |
| Discontinued operations, net of income taxes | (56.6) | (11.2) | (58.3) | (24.7) |
| Net income attributable to noncontrolling interests | (2.0) | (4.6) | (9.3) | (15.5) |
| **Net income attributable to FMC stockholders** | $17.9 | $90.0 | $266.8 | $314.0 |

(1) Our non-operating pension and postretirement costs are defined as those costs related to interest, expected return on plan assets, amortized actuarial gains and losses and the impacts of any plan curtailments or settlements. These costs are primarily related to changes in pension plan assets and liabilities which are tied to financial market performance and we consider these costs to be outside our operational performance. We exclude these non-operating pension and postretirement costs from our segments as we believe that removing them provides a better understanding of the underlying profitability of our businesses, provides increased transparency and clarity in the performance of our retirement plans and enhances period-over-period comparability. We continue to include the service cost and amortization of prior service cost in our operating segments noted above. We believe these elements reflect the current year operating costs to our businesses for the employment benefits provided to active employees.

(2) Charges related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting for acquisitions and costs incurred associated the completion of acquisitions. Charges for the three and nine months ended September 30, 2013, represented amortization of inventory fair value step-up and professional fees associated with the completion of our Epax acquisition within our FMC Health and Nutrition segment. The charges for the three and nine month periods ended September 30, 2012 relate to a number of acquisitions completed in 2011 and in the second quarter of 2012. On the condensed consolidated statements of income, the charges associated with inventory fair value step-up are included in “Costs of sales and services” and fees associated with concluding the acquisitions are included in "Selling, general and administrative expenses".

The following chart, which is provided to assist the readers of our financial statements, depicts certain after-tax charges (gains). These items are excluded in the measures we use to evaluate business performance and determine certain performance-based compensation. These after-tax items are discussed in detail within the “Other results of operations” section that follows. Additionally, the chart below discloses our Non-GAAP financial measure “Adjusted after-tax earnings from continuing operations attributable to FMC stockholders” reconciled from the GAAP financial measure “Net income attributable to FMC stockholders”. We believe that this measure provides useful information about our operating results to investors and securities analysts. We also believe that excluding the effect of restructuring and other income and charges, non-operating pension and postretirement charges, acquisition/divestiture related charges and certain tax adjustments from operating results allows management and investors to compare more easily the financial performance of our underlying businesses from period to period. This measure should not be considered as a substitute for net income (loss) or other measures of performance or liquidity reported in accordance with GAAP.

*ADJUSTED EARNINGS RECONCILIATION*

*(in Millions)*

| 2013 | Three Months Ended September 30 | 2012 | Nine Months Ended September 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| **Net income attributable to FMC stockholders (GAAP)** | $17.9 | $90.0 | $266.8 | $314.0 |
| Corporate special charges (income), pre-tax | 44.5 | 14.2 | 84.0 | 42.6 |
| Income tax expense (benefit) on Corporate special charges (income) | (16.2) | (5.3) | (31.1) | (15.9) |
| Corporate special charges (income), net of income taxes | 28.3 | 8.9 | 52.9 | 26.7 |
| Discontinued operations, net of income taxes | 56.6 | 11.2 | 58.3 | 24.7 |
| Tax adjustments | 7.4 | (3.0) | 9.1 | (1.9) |
| **Adjusted after-tax earnings from continuing operations attributable to FMC stockholders (Non-GAAP)** | $110.2 | $107.1 | $387.1 | $363.5 |

In the discussion below, please refer to our chart titled "Segment Results Reconciliation" within the Results of Operations section. All comparisons are between the periods unless otherwise noted.

### Segment Results

For management purposes, segment operating profit is defined as segment revenue less operating expenses (segment operating expenses consist of costs of sales and services, selling, general and administrative expenses and research and development expenses). We have excluded the following items from segment operating profit: corporate staff expense, interest income and expense associated with corporate debt facilities and investments, income taxes, gains (or losses) on divestitures of businesses, restructuring and other charges (income), non-operating pension and postretirement charges, investment gains and losses, loss on extinguishment of debt, asset impairments, Last-in, First-out ("LIFO") inventory adjustments, acquisition/divestiture related charges, and other income and expense items.

Information about how some of these items relate to our businesses at the segment level is discussed in Note 19 of our condensed consolidated financial statements filed in this Form 10-Q and in Note 19 of our consolidated financial statements in our 2012 Form 10-K.

In April 2013, we made the decision to simplify our organizational structure to focus on three core business segments. The new segments better reflect the markets where we participate and lead today, and where we expect to grow in the future. Also, beginning in the third quarter of 2013, our FMC Peroxygens segment has been accounted for as a discontinued operation.

For more information on these presentation changes see Notes 10 and 19 to our condensed consolidated financial statements included within this Form 10-Q.

The Segment Results as discussed below for all periods presented have been updated to reflect the presentation change and reporting of FMC Peroxygens as a discontinued operation.

### FMC Agricultural Solutions

*($ in Millions)*

| 2013 | Three Months Ended September 30 | 2012 | Nine Months Ended September 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $530.2 | $423.6 | 1,468.0 | 1,271.4 |
| Operating Profit | 114.2 | 100.9 | 402.2 | 343.7 |

### Three Months Ended September 30, 2013 vs. 2012

Revenue of $530.2 million increased approximately 25 percent versus the prior year quarter due to sales growth in Latin America, North America and Asia offset by declines in Europe/Middle East/Africa ("EMEA").

Latin America sales of $359.3 million increased 34 percent due primarily to Brazil reflecting strong market conditions, increased planted area for key crops, volume growth in herbicide and insecticide sales for soybeans and growth from new and recently introduced product. North America sales of $67.5 million increased 22 percent driven by strong demand for herbicides partially offset by weaker pest pressures compared to last year that reduced rescue insecticide demand. Revenue in Asia of $75.2 million increased 13 percent reflecting sales growth in Australia, India, China and Thailand markets. EMEA declined 17 percent to $28.2 million primarily due to lower insecticide sales.

FMC Agricultural Solutions' operating profit of $114.2 million increased approximately 13 percent compared to the year-ago quarter, reflecting the sales growth described in the preceding paragraph, impacted by geographic mix and unfavorable currency impact. Selling, general and administrative costs were approximately $3 million higher compared to the prior year due to increased spending on growth initiatives and higher people-related costs.

### Nine Months Ended September 30, 2013 vs. 2012

Revenue of $1,468.0 million increased approximately 15 percent versus the prior year period due to sales growth in North America, Latin America and Asia, partially offset by declines in EMEA.

Sales in Latin America of $698.6 million increased 14 percent driven by Brazil volume growth in herbicide and insecticide sales for soybeans, including growth from new and recently launched product. Sales in North America of $426.8 million increased 30 percent driven by strong demand for pre-emergent herbicides and at-plant insecticides as well as growth from new product introductions. Revenue in Asia of $234.3 million increased 14 percent reflecting sales growth in China, Indonesia, Australia and a number of other key countries. EMEA declined 13 percent to $108.3 million primarily due to unfavorable weather conditions and lower insecticide sales.

FMC Agricultural Solutions' operating profit of $402.2 million increased approximately 17 percent compared to the year-ago period, reflecting the sales growth described in the preceding paragraph, a favorable geographic/product mix and selected price increases. Selling, general and administrative costs were approximately $5 million higher compared to the prior year due to increased spending on growth initiatives and higher people-related costs.

In 2013, we expect full-year revenue percentage growth in the high-teens reflecting increased volumes due to strong market conditions and growth from new and recently introduced products, including new fungicides, as well as our direct market access initiatives in Asia and Latin America. We expect full-year segment operating profit to grow in the mid- to high-teens percentage, driven by sales gains partially offset by increased selling, general and administrative and research and development spending to support growth.

#### Certain Regulatory Issues

In 2009, our bifenthrin product was excluded from the European Commission's official list of approved pesticides. We submitted for reconsideration of that decision and in 2012 bifenthrin was re-approved for use in the European Union. FMC has submitted for registrations in EU Member States. We can resume selling bifenthrin in the European market once the registrations are approved by the Member States. With the exception of France, we expect that most registrations will be approved over the next 24 months; due to the continued inclusion of bifenthrin on the French “Grenelle” list of pesticides we cannot predict when we may regain a French registration. We believe that the Grenelle listing was unwarranted and contrary to French administrative law, and we challenge that decision. In July 2013, the French Conseil d' Etat court dismissed our challenge. During 2013, we will not sell any bifenthrin for agricultural use into the EU, similar to the prior year, and the absence of such sales will not have a material effect on the Company's financial condition or results of operations.

We intend to defend vigorously all our products in the U.S., EU and other countries as our pesticide products are reviewed in the ordinary course of regulatory programs during 2013 as part of the ongoing cycle of re-registration of our pesticide products around the world. In September 2013, the Brazilian health surveillance agency informed us that they intend to review carbofuran along with six other major pesticides during 2013-14, but has yet to issue any formal announcement that identifies its specific concerns or preliminary position on re-registration. We are cooperating and defending our product in this process. Under the Brazilian regulatory process, any recommendation would require public notice and comment as well as concurrence from the Brazilian environmental and agricultural ministries before any regulatory change is effective. Thus, we do not expect any material sales impact due to regulatory reviews in Brazil during 2013.

### FMC Health and Nutrition

*($ in Millions)*

| 2013 | Three Months Ended September 30 | 2012 | Nine Months Ended September 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $190.4 | $173.7 | 572.2 | 512.7 |
| Operating Profit | 41.1 | 40.3 | 129.1 | 126.0 |

### Three Months Ended September 30, 2013 vs. 2012

Revenue was $190.4 million, an increase of approximately 10 percent versus the prior-year quarter. Revenue from acquisitions increased sales by approximately eight percent while favorable pricing and currency impacts increased sales by one percent, respectively.

Segment operating profit of $41.1 million increased two percent versus the year ago quarter as revenue growth was slightly offset by acquisition-related start up expenses, increased raw material costs, primarily seaweed, and costs to improve our manufacturing capabilities which we refer to as Manufacturing Excellence.

### Nine Months Ended September 30, 2013 vs. 2012

Revenue was $572.2 million, an increase of approximately 12 percent versus the prior-year period. This increase was due to volume increases of four percent in core product lines, revenue from acquisitions which increased sales by five percent and favorable pricing and foreign currency impacts which increased sales by two and one percent, respectively.

Segment operating profit of $129.1 million increased by two percent versus the prior year period as revenue growth was partially offset by acquisition related costs, increased raw material costs and Manufacturing Excellence costs. Selling, general and administrative costs also increased approximately $1.9 million compared to the prior year due to increased spending on growth initiatives.

In 2013, we expect full-year revenue to be up mid-teens percent driven by higher volumes and contributions from acquisitions. Full-year segment operating profit are expected to grow in high single digits percent with sales gains in core segment product lines and benefits from the Epax acquisition partially offset by acquisition-related and Manufacturing Excellence costs.

### FMC Minerals

*($ in Millions)*

| 2013 | Three Months Ended September 30 | 2012 | Nine Months Ended September 30 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $237.8 | $224.6 | $706.8 | $710.3 |
| Operating Profit | 27.7 | 34.6 | 92.1 | 127.1 |

### Three Months Ended September 30, 2013 vs. 2012

Revenue of $237.8 million increased by approximately six percent versus the prior-year quarter. Volume gains in both Alkali and Lithium were partially offset by unfavorable pricing in our Alkali division.

Alkali revenues of $181.2 million increased five percent as lower average export prices, particularly in Asia were more than offset by higher overall volumes.

Lithium revenues of $56.6 million increased eight percent compared to the prior year quarter. Increased volumes contributed six percent and favorable pricing added two percent to sales growth.

Segment operating profit of $27.7 million decreased approximately 20 percent versus the year ago quarter. Operating profit was impacted by lower average export pricing, one-time production factors, and a scheduled maintenance shutdown partially by higher global soda ash sales volumes. Selling, general and administrative costs also increased approximately $1 million compared to the prior year.

### Nine Months Ended September 30, 2013 vs. 2012

Revenue of $706.8 million, was essentially flat period over period. Unfavorable pricing in Alkali and volume declines in our Lithium division negatively impacted sales by four percent and two percent, respectively. These declines were offset by increased volumes and higher freight billings in Alkali which favorably impacted sales by four and two percent.

Alkali revenues of $555.1 million increased two percent over the prior year due to higher freight billings, while volume gains of five percent were completely offset by reduced pricing.

Lithium revenues of $151.7 million decreased eight percent compared to the prior year. Lithium experienced reduced volumes earlier in the year which impacted revenue by 10 percent. These volume declines were partially offset by favorable pricing and mix impacting sales by two percent. The lower volumes were due to production constraints, the effects of recent labor disputes in Chilean ports and the impact of snow blocking the Jama Pass between Argentina and Chile which provides critical access to and from Chilean ports.

Segment operating profit of $92.1 million decreased approximately 28 percent versus the prior year. The decrease is consistent with that of the three months ended September 30, 2013 noted above, which was primarily due to lower average export pricing. Selling, general and administrative costs also decreased approximately $4 million compared to the prior year due to the benefits of restructuring activities within our Lithium division.

In 2013, we expect full-year revenue percentage growth flat to up low-single percent driven primarily by volumes and higher prices in soda ash in the second half of the year as well as Lithium operational improvements in the fourth quarter. We expect full-year segment operating profit to decline by low to mid-20 percent, reflecting Lithium margin improvements offset by one-time Alkali operational challenges and lower average export soda ash prices.

### Other Results of Operations

#### Corporate and other

Corporate and other expenses are included as a component of the line item “Selling, general and administrative expenses” except for LIFO related charges that are included as a component of "Cost of sales and services" on our condensed consolidated statements of income.

### Three Months Ended September 30, 2013 vs. 2012

Corporate and other expenses of $20.1 million in the third quarter of 2013 increased by $3.9 million from $16.2 million in the same period in 2012. The increase period over period is due to increased costs to support growth initiatives within our businesses including a transformation of our finance organization. This transformation is similar to past initiatives to improve our organization.

### Nine Months Ended September 30, 2013 vs. 2012

Corporate and other expenses of $60.2 million in the nine months of 2013 increased slightly from $56.6 million in the same period in 2012. The increase period over period is consistent with the three months ended September 30, 2013 noted above.

#### Interest expense, net

### Three Months Ended September 30, 2013 vs. 2012

Interest expense, net for the third quarter of 2013 was $9.8 million as compared to the third quarter of 2012 of $9.8 million.

### Nine Months Ended September 30, 2013 vs. 2012

Interest expense, net for the nine months ended September 30, 2013 was $31.4 million as compared to $30.3 million in 2012.

#### Corporate special (charges) income

### Three Months Ended September 30, 2013 vs. 2012

#### Restructuring and other charges (income)

These charges totaled $32.1 million in the third quarter of 2013 compared to $5.5 million in the third quarter of 2012. Our restructuring and other charges (income) are comprised of restructuring, asset disposals and other charges (income). See the table and further discussion regarding our restructuring and other charges (income) in Note 7 to our condensed consolidated financial statements included in this Form 10-Q. Restructuring and asset disposal charges in 2013 of $0.5 million were primarily associated with the announced Lithium restructuring. Other charges (income) net in 2013 of $31.6 million primarily related to charges associated with collaboration and license agreements entered into by our FMC Agricultural Solutions segment for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development. The rights and technology obtained is referred to as in-process research and development and in accordance with GAAP, the amounts paid were expensed as incurred since they were acquired outside of a business combination.

Restructuring and asset disposal charges in 2012 of $0.1 million were primarily associated with continuing charges related to facility restructurings and shutdowns which were announced in years prior to 2012. Other charges (income) net in 2012 of $5.4 million were primarily related to charges associated with collaboration and license agreements entered into by our FMC Agricultural Solutions segment for the purpose of obtaining certain technology and intellectual property rights relating to new compounds still under development.

The liabilities associated with the restructuring charges listed above are also included within Note 7 to our condensed consolidated financial statements included in this Form 10-Q. We believe the restructuring plans implemented are on schedule and the benefits and savings either have been or will be achieved.

#### Non-operating pension and postretirement charges

The charge for the three months ended September 30, 2013 was $5.7 million compared to $8.1 million for the three months ended September 30, 2012. The decrease was primarily the result of lower amortization of actuarial losses of $7.5 million attributable to a lengthening of the average remaining service period used for amortization purposes as a result of a completed actuarial study indicating overall decreases in retirement and termination activity. Lower interest costs associated with decreases in rates amounted to approximately $2.0 million of the decrease as well. Offsetting these decreases was a settlement charge of $7.1 million associated with the acceleration of previously deferred actuarial losses triggered by lump-sum payouts to former executives. These expenses are included as a component of the line item “Selling, general and administrative expenses” on our condensed consolidated statements of income.

#### Acquisition related charges

Charges related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting for acquisitions and certain professional fees associated the completion of acquisitions. Charges for the three and nine months ended September 30, 2013, represented amortization of inventory fair value step-up of $2.1 million and certain professional fees of $4.6 million associated with the completion of our Epax acquisition within our FMC Health and Nutrition segment. The charges for the three and nine month periods ended September 30, 2012, representing amortization of inventory fair value step-up relate to a number of acquisitions completed in 2011 and in the second quarter of 2012. On the condensed consolidated statements of income, the charges associated with inventory fair value step-up are included in “Costs of sales and services” and fees associated with concluding the acquisitions are included in "Selling, general and administrative expenses".

### Nine Months Ended September 30, 2013 vs. 2012

#### Restructuring and other charges (income)

These charges totaled $47.3 million in the nine months ended September 30, 2013 compared to $9.1 million in 2012. Restructuring and asset disposal charges in 2013 of $12.2 million were primarily associated with the announced Lithium restructuring. Other charges (income) net in 2013 of $35.1 million were primarily related the items associated with the three months ended September 30, 2013, as discussed previously.

Restructuring and asset disposal charges in 2012 of $1.8 million were primarily associated with continuing charges related to facility restructurings and shutdowns which were announced in years prior to 2012. Other charges (income) net in 2012 of $7.3 million were primarily related the items associated with the three months ended September 30, 2013, as discussed previously.

#### Non-operating pension and postretirement charges

The charge for the nine months ended September 30, 2013 was $30.0 million compared to $26.3 million for the nine months ended September 30, 2012. The increase in charges were primarily the result of a settlement charge of $7.1 million, partially offset by lower interest costs of $4.5 million.

#### Acquisition/divestiture related charges

Charges for the nine months ended September 30, 2013 of $6.7 million related to the items noted within the preceding three months ended September 30, 2013 discussion. Charges for the nine months ended September 30, 2012 of $7.2 million related to the expensing of the inventory fair value step-up resulting from the application of purchase accounting associated with acquisitions completed prior to 2012.

#### Provision for income taxes

### Three Months Ended September 30, 2013 vs. 2012

Provision for income taxes was $32.0 million resulting in an effective tax rate of 29.5 percent compared to a provision of $29.9 million resulting in an effective tax rate of 22.0 percent for the three months ended September 30, 2013 and 2012, respectively. The increase in the effective tax rate was primarily impacted by the mix of income among subsidiaries and tax charges associated with the expected sale of our discontinued FMC Peroxygens segment. See Note 16 to our condensed consolidated financial statements included in this Form 10-Q for more information.

### Nine Months Ended September 30, 2013 vs. 2012

Provision for income taxes was $113.1 million resulting in an effective tax rate of 25.3 percent compared to a provision of $113.2 million resulting in an effective tax rate of 24.2 percent for the nine months ended September 30, 2013 and 2012, respectively. The change period over period was impacted by the items described in the three months ended September 30, 2013, as discussed in the previous paragraph.

#### Discontinued operations, net of income taxes

Our discontinued operations represent our discontinued FMC Peroxygens segment results as well as adjustments to retained liabilities from previous discontinued operations. The primary liabilities retained include environmental liabilities, other postretirement benefit liabilities, self-insurance, long-term obligations related to legal proceedings and historical restructuring activities.

### Three Months Ended September 30, 2013 vs. 2012

Discontinued operations, net of income taxes represented a loss of $56.6 million for the three months ended September 30, 2013, compared to a charge of $11.2 million for the three months ended September 30, 2012. The increase was a result of a charge of $65.0 million ($50.8 million after tax) associated with our discontinued FMC Peroxygens segment. For more information on our discontinued operations, net of income taxes see Note 10 to our condensed consolidated financial statements included in this Form 10-Q.

### Nine Months Ended September 30, 2013 vs. 2012

Discontinued operations, net of income taxes represented a loss of $58.3 million for the nine months ended September 30, 2013, compared to a charge of $24.7 million for the nine months ended September 30, 2012. The increase was a result of a charge of $65.0 million ($50.8 million after tax) associated with our discontinued FMC Peroxygens segment, partially offset by 2012 restructuring activity in Spain. For more information on our discontinued operations, net of income taxes see Note 10 to our condensed consolidated financial statements included in this Form 10-Q.

#### Net income attributable to FMC stockholders

### Three Months Ended September 30, 2013 vs. 2012

Net income attributable to FMC stockholders decreased to $17.9 million for the three months ended September 30, 2013, from $90.0 million for the three months ended September 30, 2012. The decrease was primarily due to charges recorded to discontinued operations associated with our discontinued FMC Peroxygens segment during the current quarter, higher restructuring and other charges and corporate and other expenses. Partially offsetting these costs are higher operating profits in FMC Agricultural Solutions.

### Nine Months Ended September 30, 2013 vs. 2012

Net income attributable to FMC stockholders decreased to $266.8 million for the nine months ended September 30, 2013, from $314.0 million for the nine months ended September 30, 2012. The decrease was primarily due to charges recorded to discontinued operations associated with our discontinued FMC Peroxygens segment during the third quarter 2013. This decrease was partially offset by higher operating profits in FMC Agricultural Solutions.

### LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents at September 30, 2013 and December 31, 2012, were $109.6 million and $77.1 million, respectively. Of the cash and cash equivalents balance at September 30, 2013, $90.7 million were held by our foreign subsidiaries. Our intent is to reinvest permanently the earnings of the majority of our foreign subsidiaries and therefore we have not recorded taxes that would be payable if we repatriated these earnings. However, in the third quarter of 2013, we changed our assertion on the portion of our foreign subsidiaries unremitted earnings that we intend to repatriate upon the sale of our discontinued FMC Peroxygens segment and have recorded the taxes that would be payable upon such repatriation. In the event that additional funds from our foreign subsidiaries are repatriated to the U.S., we would be required to accrue and pay U.S. taxes on those amounts.

In June 2013, we commenced a $1.5 billion commercial paper program supported by our credit facility. This program allows the Company to borrow at rates generally more favorable that those available under our credit facility. The Company has used proceeds from the commercial paper program for general corporate purposes. At September 30, 2013, the average effective interest rate on these borrowings was 0.35%.

On August 5, 2013, we entered into an Amendment and Consent No. 1 (the "Amendment") to our credit agreement, dated as of August 5, 2011. The Amendment, among other things, extended the termination date of the credit facility to August 5, 2017 from August 5, 2016.

At September 30, 2013, we had total debt of $1,714.2 million as compared to $964.4 million at December 31, 2012. The increase was primarily associated with higher borrowings under our commercial paper program to support strategic growth opportunities and working capital requirements. Total debt included $771.8 million and $908.8 million of long-term debt (excluding current portions of $23.3 million and $5.7 million) at September 30, 2013 and December 31, 2012, respectively. Short-term debt, which consists primarily of borrowings under our commercial paper program, increased from $49.9 million at December 31, 2012 to $919.1 million at September 30, 2013.

### Statement of Cash Flows

*Cash provided (required) by operating activities was $380.6 million and $368.9 million for the nine months ended September 30, 2013 and 2012, respectively.*

The table below presents the components of net cash provided (required) by operating activities.

*(in Millions)*

| 2013 | Nine Months Ended September 30 | 2012 |
| --- | ---: | ---: |
| Income from continuing operations before equity in (earnings) loss of affiliates, interest income and expense and income taxes | $479.4 | $498.0 |
| Significant non-cash expenses (1) | 154.1 | 142.1 |
| **Operating income before non-cash expenses (Non-GAAP)** | **633.5** | **640.1** |
| Change in trade receivables (2) | (93.9) | (82.6) |
| Change in inventories (3) | (14.0) | (143.9) |
| Change in accounts payable | 0.6 | 3.7 |
| Change in accrued rebates (4) | 194.8 | 163.3 |
| Change in advance payments from customers (5) | (122.1) | (66.6) |
| Change in all other operating assets and liabilities (6) | 18.7 | (5.2) |
| Restructuring and other spending (7) | (8.8) | (0.6) |
| Environmental spending, continuing, net of recoveries (8) | (4.3) | (4.3) |
| Pension and other postretirement benefit contributions (9) | (63.1) | (72.7) |
| **Cash basis operating income (Non-GAAP)** | **541.4** | **431.2** |
| Interest payments | (29.5) | (24.9) |
| Tax payments | (124.6) | (30.0) |
| Excess tax benefits from share-based compensation | (6.7) | (7.4) |
| **Cash provided (required) by operating activities** | **$380.6** | **$368.9** |

(1) Represents the sum of depreciation, amortization, non-cash asset write downs, share-based compensation, and pension charges.

(2) Overall, the use of cash for trade receivables is primarily due to revenue increases, particularly for Agricultural Solutions' sales in Brazil where terms are significantly longer than the rest of our businesses. Amounts for both periods include carry-over balances remaining to be collected in Latin America, where collection periods are measured in months rather than weeks.

(3) The change in inventory from 2012 to 2013 was due to timing of inventory build in our FMC Agricultural Solutions segment to satisfy 2013 season demand. The majority of the build to satisfy the 2013 demand occurred in the latter of 2012. Higher sales also contributed to the change year over year.

(4) These rebates are associated with our FMC Agricultural Solutions segment, primarily in North America and Brazil and generally settle in the fourth quarter of each year. The increase from 2012 to 2013 is primarily associated with the increased sales for FMC Agricultural Solutions in North America.

(5) The advance payments from customers represent advances from our FMC Agricultural Solutions segment customers. The use of cash for each year presented is consistent with our sales increases year over each year. We received substantial increases in advance payments from customers at the end of 2012 related to 2013 season compared to the prior period.

(6) Changes in all periods presented primarily represent timing of payments associated with all other operating assets and liabilities.

(7) See Note 7 in our condensed consolidated financial statements included in this Form 10-Q for further details.

(8) Included in our income for both periods presented are environmental charges of $3.0 million, respectively, for environmental remediation at our operating sites. The amounts in 2013 will be spent in periods beyond third quarter 2013. The amounts in this row represent environmental remediation spending at our operating sites which were recorded against pre-existing reserves, net of recoveries.

(9) Amounts include voluntary contributions to our U.S. defined benefit plan of $40.0 million and $65.0 million, respectively.

*Cash required by operating activities of discontinued operations was $31.4 million and $36.3 million for the nine months ended September 30, 2013 and 2012, respectively.*

Both periods include our discontinued FMC Peroxygens segment which required cash of $5.2 million in 2013 compared to an inflow of cash of $2.2 million in the prior years. This change was due to reduced operating income period over period. Additionally, cash required by operating activities of discontinued operations includes a $13.9 million insurance recovery received during the second quarter of 2013, which did not occur in 2012. This recovery partially offset higher environmental spending related to discontinued operations during the nine months ended September 30, 2013, compared to the prior year period.

*Cash required by investing activities of continuing operations was $555.3 million and $251.3 million for the nine months ended September 30, 2013 and 2012, respectively.*

The increase in spending during the nine months ended September 30, 2013, as compared to the same period in 2012 was primarily due to the Epax acquisition completed in third quarter of 2013 and higher spending on capital expenditures compared to 2012 to support growth initiatives.

*Cash required by investing activities of discontinued operations was $15.2 million and $19.0 million for the nine months ended September 30, 2013 and 2012, respectively.*

The decrease is due to reduced spending associated with capital expenditures.

*Cash provided (required) by financing activities was $253.7 million and $(137.1) million for the nine months ended September 30, 2013 and 2012, respectively.*

The change in financing activities is primarily due to borrowings under our commercial paper ("CP") program which was implemented during the second quarter of 2013. The CP borrowings were partially offset by repayments of borrowings under our committed credit facility, the acquisition of an additional 6.25% ownership interest in our consolidated entity FMC Wyoming and higher dividends paid and share repurchases compared to 2012. See Note 13 in our condensed consolidated financial statements included in this Form 10-Q for further details on the acquisition of additional ownership interest in FMC Wyoming.

### Other potential liquidity needs

Our cash needs for 2013 include operating cash requirements, capital expenditures, scheduled mandatory payments of long-term debt, dividend payments, share repurchases, contributions to our pension plans, environmental and asset retirement obligation spending and restructuring. We plan to meet our liquidity needs through available cash, cash generated from operations, commercial paper issuances and borrowings under our committed revolving credit facility. At September 30, 2013 our remaining borrowing capacity under our credit facility was $530.8 million (which include borrowings under our commercial paper program).

Our discontinued FMC Peroxygens segment is currently held for sale and we believe the sale to be completed within one year.

Projected 2013 capital expenditures as well as expenditures related to contract manufacturers are expected to be approximately 35 percent higher than 2012 levels, primarily to increase capacity in our FMC Health and Nutrition and FMC Minerals segments.

Projected 2013 spending includes approximately $40 million of net environmental remediation spending. This spending does not include expected spending of approximately $10 million associated with capital projects relating to environmental control facilities. Also, we expect to spend approximately $30 million in 2013 for environmental compliance costs, which we will include as a component of costs of sales and services in our condensed consolidated statements of income since these amounts are not covered by established reserves. Capital spending to expand, maintain or replace equipment at our production facilities may trigger requirements for upgrading our environmental controls, which may increase our spending for environmental controls over the foregoing projections.

In order to reduce future funding volatility in our U.S. qualified defined benefit pension plan, we have made voluntary contributions through September 30, 2013 of $40.0 million. These contributions are in excess of the minimum requirements. We made voluntary contributions of $65 million in 2012. We do not believe that these projected contributions will have a significant negative impact on our current and future liquidity needs. However, any volatility of interest rates or negative equity returns may require greater contributions to the U.S. Plan in the future.

For the nine months ended September 30, 2013 and 2012, we paid $55.6 million and $35.4 million, respectively, in dividends declared in previous periods. On October 17, 2013, we paid dividends totaling $18.1 million to our shareholders of record as of September 30, 2013. This amount is included in “Accrued and other liabilities” on the condensed consolidated balance sheet as of September 30, 2013.

On April 23, 2013 our Board-authorized the repurchase of up to $500.0 million of our common shares. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. The authorization of April 23, 2013, replaced the previous authority under which $134.9 million was unused.

During the nine months ended September 30, 2013, we repurchased 4,998,843 shares under the publicly announced repurchase program for $309.9 million. At September 30, 2013, $250 million remained unused under our Board-authorized repurchase program.

In July 2013, we entered into an accelerated share repurchase agreement (ASR) and paid $250.0 million to a financial institution for an initial delivery of approximately 3.2 million shares, which reduced the our shares outstanding at July 31, 2013. The repurchse is taking place under our previously announced $500.0 million share repurchase program. The value of the initial shares received on the date of purchase was $200.0 million, reflecting a $63.58 price per share which was recorded as a treasury share purchase for purposes of calculating earnings per share. We recorded the remaining $50.0 million as a forward contract indexed to our common stock in additional paid in capital. Final settlement of the ASR, corresponding to the date we will purchase the remaining $50.0 million of common stock under the ASR, is expected to be completed by year end, but may be completed sooner under certain circumstances. The final number of shares that the company is repurchasing under the ASR, the timing of the final settlement, and the aggregate cost will depend upon prevailing market conditions and the final discounted volume-weighted average share price over the term of the ASR.

The Dodd-Frank Wall Street Reform and Consumer Protection Act (the "Dodd-Frank Act") was signed into law in 2010. Title VII of the Act contains significant changes in the ways derivatives are regulated. Several U.S. government regulatory agencies and departments are charged with developing the many regulations required under the new law. While the exact effects on FMC cannot be known until final regulations are promulgated, we believe they will not adversely affect our liquidity in a material way.

### Commitments and Contingencies

See Note 18 to our condensed consolidated financial statements included in this Form 10-Q.

### Contractual Commitments

Information related to our contractual commitments at December 31, 2012 can be found in a table included within Part II, Item 7 of our 2012 Form 10-K. There have been no significant changes to our contractual commitments during the nine months ended September 30, 2013.

### Climate Change

A detailed discussion related to climate change can be found in Part II, Item 7 of our 2012 Form 10-K. There have been no material changes related to climate change from the information reported in our 2012 10-K.

### Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

### Fair-Value Measurements

See Note 17 to our condensed consolidated financial statements in this Form 10-Q for additional discussion surrounding our fair value measurements.

### DERIVATIVE FINANCIAL INSTRUMENTS AND MARKET RISKS

Our earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in commodity prices, interest rates and foreign currency exchange rates. Our policy is to minimize exposure to our cash flow over time caused by changes in commodity, interest and currency exchange rates. To accomplish this, we have implemented a controlled program of risk management consisting of appropriate derivative contracts entered into with major financial institutions.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. The range of changes chosen reflects our view of changes that are reasonably possible over a one-year period. Market-value estimates are based on the present value of projected future cash flows considering the market rates and prices chosen.

At September 30, 2013, our financial instrument position was a net liability of $11.9 million compared to a net liability of $2.2 million at December 31, 2012. The change in the net financial instrument position was primarily due to larger unrealized gains in our commodity and foreign exchange portfolios.

Since our risk management programs are generally highly effective, the potential loss in value for each risk management portfolio described below would be largely offset by changes in the value of the underlying exposure.

### Commodity Price Risk

Energy costs are approximately seven percent of our cost of sales and services and are diversified among coal, electricity, and natural gas. We attempt to mitigate our exposure to increasing energy costs by hedging the cost of future deliveries of natural gas and by entering into fixed-price contracts for the purchase of coal and fuel oil. To analyze the effect of changing energy prices, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in energy market prices from their levels at September 30, 2013 and December 31, 2012, with all other variables (including interest rates) held constant. A 10 percent increase in energy market prices would result in an decrease in the net liability position of $3.0 million at September 30, 2013, compared to a $4.6 million decrease of the net liability position at December 31, 2012. As a result, at September 30, 2013 the net liability position would have become a net asset. A 10 percent decrease in energy market prices would result in a increase of $2.9 million in the net liability position at September 30, 2013, compared to an increase of $4.1 million of the net liability position at December 31, 2012.

Our FMC Agricultural Solutions segment enters into contracts with certain customers in Brazil to exchange our products for future physical delivery of soybeans. To mitigate the price risk associated with these barter contracts, we enter into offsetting derivatives to hedge our exposure. As of September 30, 2013 and December 31, 2012 our net financial instrument position was immaterial.

### Foreign Currency Exchange Rate Risk

The primary currencies for which we have exchange rate exposure are the U.S. dollar versus the euro, the U.S. dollar versus the Chinese yuan and the U.S. dollar versus the Brazilian real. Foreign currency debt and foreign exchange forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange forward contracts are also used to hedge firm and highly anticipated foreign currency cash flows.

To analyze the effects of changing foreign currency rates, we have performed a sensitivity analysis in which we assume an instantaneous 10 percent change in the foreign currency exchange rates from their levels at September 30, 2013 and December 31, 2012, with all other variables (including interest rates) held constant. A 10 percent strengthening of hedged currencies versus our functional currencies would have resulted in an decrease of $16.4 million in the net liability position at September 30, 2013, compared to a decrease of $5.5 million in the net liability position at December 31, 2012. As a result, at September 30, 2013 the net liability position would have become a net asset. A 10 percent weakening of hedged currencies versus our functional currencies would have resulted in an increase of $24.7 million in the net liability position at September 30, 2013, compared to a increase of $4.3 million in the net liability position at December 31, 2012.

### Interest Rate Risk

One of the strategies that we can use to manage interest rate exposure is to enter into interest rate swap agreements. In these agreements, we agree to exchange, at specified intervals, the difference between fixed and variable interest amounts calculated on an agreed-upon notional principal amount. As of September 30, 2013 and December 31, 2012, we had no interest rate swap agreements.

Our debt portfolio, at September 30, 2013, is composed of 45 percent fixed-rate debt and 55 percent variable-rate debt. The variable-rate component of our debt portfolio principally consists of borrowings under our Credit Facility, commercial paper program, variable-rate industrial and pollution control revenue bonds, and amounts outstanding under foreign subsidiary credit lines. Changes in interest rates affect different portions of our variable-rate debt portfolio in different ways.

Based on the variable-rate debt in our debt portfolio at September 30, 2013, a one percentage point increase in interest rates then in effect would have increased gross interest expense by $7.1 million and a one percentage point decrease in interest rates then in effect would have decreased gross interest expense by $2.6 million for the nine months of September 30, 2013.

## Market risk

As filed, 207 characters.

The information required by this item is provided in “Derivative Financial Instruments and Market Risks,” under ITEM 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations.

## Controls and procedures

As filed, 3,507 characters.

(a) Evaluation of disclosure controls and procedures. Based on management’s evaluation (with the participation of the Company’s Chief Executive Officer and Chief Financial Officer), the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2013, the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) are effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Change in Internal Controls. There have been no changes in internal control over financial reporting that occurred during the quarter ended September 30, 2013, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

### REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders

FMC Corporation:

We have reviewed the condensed consolidated balance sheet of FMC Corporation and subsidiaries as of September 30, 2013, the related condensed consolidated statements of income and comprehensive income for the three-month and nine-month periods ended September 30, 2013 and 2012, and the related condensed consolidated statements of cash flows for the nine-month periods ended September 30, 2013 and 2012. These condensed consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should be made to the condensed consolidated financial statements referred to above for them to be in conformity with U.S. generally accepted accounting principles.

We have previously audited, in accordance with standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of FMC Corporation and subsidiaries as of December 31, 2012, and the related consolidated statements of income, comprehensive income, cash flows, and changes in equity for the year then ended (not presented herein); and in our report dated February 19, 2013, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2012, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

**/s/** KPMG LLP

Philadelphia, Pennsylvania

October 29, 2013

## Risk factors

As filed, 500 characters.

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part 1, Item 1A "Risk Factors" of our 2012 Form 10-K. The risks described in our Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could suffer.

Filed Oct 29, 2013.
Source: SEC EDGAR, the filing index for accession 0000037785-13-000050. Last ingested by Listed: Nov 13, 2026, 16:31 ET. No prices; not investment advice.
